These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10383720)

  • 41. Is CD56 a specific and reliable neuroendocrine marker for discriminating between endocrine/neuroendocrine ductal carcinoma in situ and intraductal papilloma of the breast?
    Kawasaki T; Kondo T; Nakazawa T; Mochizuki K; Yamane T; Murata S; Inoue S; Tsunoda H; Katoh R
    Pathol Int; 2011 Jan; 61(1):49-51. PubMed ID: 21166944
    [No Abstract]   [Full Text] [Related]  

  • 42. Expression of Cox-2 and Bcl-2 in Paget's disease of the breast.
    Alikanoglu AS; Yildirim M; Suren D; Tutus B; Kaya V; Topal CS; Keser S; Karadayi AN; Kapucuoglu FN; Ayva S; Gunduz S
    Asian Pac J Cancer Prev; 2015; 16(3):1041-5. PubMed ID: 25735328
    [TBL] [Abstract][Full Text] [Related]  

  • 43. p53 protein expression in benign and malignant breast lesions.
    Ioakim-Liossi A; Markopoulos C; Karakitsos P; Safioleas M; Gogas J; Vaiopoulos G
    Acta Cytol; 1998; 42(4):918-22. PubMed ID: 9684577
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The phosphorylated form of connexin43 is up-regulated in breast hyperplasias and carcinomas and in their neoformed capillaries.
    Gould VE; Mosquera JM; Leykauf K; Gattuso P; Dürst M; Alonso A
    Hum Pathol; 2005 May; 36(5):536-45. PubMed ID: 15948121
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased claudin-4 expression is associated with poor prognosis and high tumour grade in breast cancer.
    Lanigan F; McKiernan E; Brennan DJ; Hegarty S; Millikan RC; McBryan J; Jirstrom K; Landberg G; Martin F; Duffy MJ; Gallagher WM
    Int J Cancer; 2009 May; 124(9):2088-97. PubMed ID: 19142967
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A useful immunohistochemical approach to evaluate intraductal proliferative lesions of the breast and to predict their prognosis.
    Omi Y; Yamamoto T; Okamoto T; Obara T; Kobayashi M
    Histol Histopathol; 2011 Jan; 26(1):79-86. PubMed ID: 21117029
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Carcinoma within solitary ductal papilloma of the breast.
    Greif F; Sharon E; Shechtman I; Morgenstern S; Gutman H
    Eur J Surg Oncol; 2010 Apr; 36(4):384-6. PubMed ID: 19646841
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fibroadenoma with "immature-like" type of usual ductal hyperplasia.
    Bezić J; Karaman I; Kunac N
    Breast Dis; 2016; 36(4):157-160. PubMed ID: 27589503
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Expression of neuronal marker protein gene product 9.5 and its clinicopathologic significance in breast cancer].
    Liu L; Zhao Q; Liang X; Du G; Lu L; Dong J; Han H
    Zhonghua Bing Li Xue Za Zhi; 2014 May; 43(5):318-20. PubMed ID: 25030864
    [TBL] [Abstract][Full Text] [Related]  

  • 50. M34 actin regulatory protein is a sensitive diagnostic marker for early- and late-stage mammary carcinomas.
    Soriano Z; Pardee JD
    Clin Cancer Res; 2004 Jul; 10(13):4437-43. PubMed ID: 15240534
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinicopathologic characteristics of male breast cancer: a report of 21 cases in radiotherapy center of hamedan, iran.
    Sedighi A; Hamed EA; Mohammadian K; Behnood S; Kalaghchi B
    Asian Pac J Cancer Prev; 2013; 14(12):7381-3. PubMed ID: 24460307
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Loss of expression and aberrant methylation of the CDH1 (E-cadherin) gene in breast cancer patients from Kashmir.
    Asiaf A; Ahmad ST; Aziz SA; Malik AA; Rasool Z; Masood A; Zargar MA
    Asian Pac J Cancer Prev; 2014; 15(15):6397-403. PubMed ID: 25124632
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular alterations in lesions of anogenital mammary-like glands and their mammary counterparts including hidradenoma papilliferum, intraductal papilloma, fibroadenoma and phyllodes tumor.
    Konstantinova AM; Vanecek T; Martinek P; Kyrpychova L; Spagnolo DV; Stewart CJR; Portelli F; Michal M; Kazakov DV
    Ann Diagn Pathol; 2017 Jun; 28():12-18. PubMed ID: 28648934
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [PIK3CA mutation is an independent indicator of malignant phenotype and prognosis in breast cancer].
    Li SY; Wang W; Li JM; Wang Z; Wen RY; Chen J; Miao XT
    Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):605-8. PubMed ID: 22325221
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CD44/cellular prion protein interact in multidrug resistant breast cancer cells and correlate with responses to neoadjuvant chemotherapy in breast cancer patients.
    Cheng Y; Tao L; Xu J; Li Q; Yu J; Jin Y; Chen Q; Xu Z; Zou Q; Liu X
    Mol Carcinog; 2014 Sep; 53(9):686-97. PubMed ID: 23681900
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sporadic invasive breast carcinomas with medullary features display a basal-like phenotype: an immunohistochemical and gene amplification study.
    Rodríguez-Pinilla SM; Rodríguez-Gil Y; Moreno-Bueno G; Sarrió D; Martín-Guijarro Mdel C; Hernandez L; Palacios J
    Am J Surg Pathol; 2007 Apr; 31(4):501-8. PubMed ID: 17414096
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Expression of Twist, E-cadherin and N-cadherin in breast carcinoma and their clinical significance].
    Ma YH; Wang K; Li L; Lu ZH; Chen J
    Zhonghua Bing Li Xue Za Zhi; 2010 Jan; 39(1):5-9. PubMed ID: 20388391
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Application of cytology in diagnosing benign changes and breast cancers.
    Sporek R
    Med Sci Monit; 2000; 6(2):373-9. PubMed ID: 11208341
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Papillomas and atypical papillomas in breast core needle biopsy specimens: risk of carcinoma in subsequent excision.
    Renshaw AA; Derhagopian RP; Tizol-Blanco DM; Gould EW
    Am J Clin Pathol; 2004 Aug; 122(2):217-21. PubMed ID: 15323138
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Id-1 overexpression in invasive ductal carcinoma cells is significantly associated with intratumoral microvessel density in ER-negative/node-positive breast cancer.
    Jang KS; Han HX; Paik SS; Brown PH; Kong G
    Cancer Lett; 2006 Dec; 244(2):203-10. PubMed ID: 16469432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.